LivaNova (LIVN)
NASDAQ: LIVN
· Real-Time Price · USD
53.44
1.16 (2.22%)
At close: Sep 26, 2025, 3:59 PM
53.72
0.52%
After-hours: Sep 26, 2025, 07:53 PM EDT
LivaNova Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiopulmonary Segment Revenue | 199.27M | 176.32M | 181.67M | 172.24M | 173.71M | 155.89M | 161.47M | 144.83M | 150.6M | 132.07M | 136.46M | 120.96M | 125.82M | 117.08M | 121.55M | 113.29M | 117.64M | 103.7M | 109.17M | 98.41M | 57.21M | 89.66M |
| Cardiopulmonary Segment Revenue Growth | +13.02% | -2.94% | +5.47% | -0.85% | +11.43% | -3.46% | +11.50% | -3.84% | +14.03% | -3.22% | +12.82% | -3.86% | +7.47% | -3.68% | +7.29% | -3.70% | +13.44% | -5.01% | +10.93% | +72.01% | -36.19% | n/a |
| Neuromodulation Segment Revenue | 151.67M | 138.89M | 137.61M | 139.86M | 142.88M | 133.87M | 136.93M | 128.88M | 133.18M | 120.72M | 127.14M | 121.83M | 117.8M | 110.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Neuromodulation Segment Revenue Growth | +9.20% | +0.93% | -1.61% | -2.11% | +6.73% | -2.23% | +6.24% | -3.23% | +10.32% | -5.04% | +4.35% | +3.43% | +6.87% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Oct 18, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Revenue | 66.78M | 59.7M | 61.62M | 52.81M | 51.26M | 54.34M | 62.56M | 48.13M | 54.46M | 49.64M | 74.78M | 40M | 47.37M | 45.13M | 48.95M | 45.72M | 56.04M | 50.82M | 54.76M | 48.53M | 35.36M | 64.1M | 12.12M | -83.87M | 92.95M | 105.04M | 96.35M | 100.34M | 91.25M | 111.13M | 99.31M | 58.35M |
| Europe Revenue Growth | +11.85% | -3.11% | +16.67% | +3.04% | -5.67% | -13.14% | +29.99% | -11.62% | +9.70% | -33.61% | +86.95% | -15.57% | +4.98% | -7.81% | +7.06% | -18.41% | +10.27% | -7.20% | +12.84% | +37.24% | -44.83% | +429.04% | -114.45% | -190.23% | -11.51% | +9.02% | -3.98% | +9.97% | -17.89% | +11.91% | +70.18% | n/a |
| Locations Excluding The United States And Europe Revenue | 97.27M | 87.99M | 85.11M | 85.48M | 87.78M | 79.95M | 74.35M | 76.4M | 79.45M | 73.51M | 46.31M | 69.2M | 68.69M | 58.78M | 71.29M | 63.7M | 64.1M | 63.45M | 76.79M | 62.69M | 68.66M | 54.72M | 6.54M | 128.61M | 122.21M | 129.56M | 114.35M | 128.15M | 123.81M | 124.41M | 114.13M | n/a |
| Locations Excluding The United States And Europe Revenue Growth | +10.55% | +3.38% | -0.42% | -2.62% | +9.79% | +7.53% | -2.68% | -3.84% | +8.08% | +58.74% | -33.08% | +0.73% | +16.86% | -17.54% | +11.91% | -0.62% | +1.03% | -17.38% | +22.49% | -8.69% | +25.48% | +737.15% | -94.92% | +5.24% | -5.67% | +13.30% | -10.77% | +3.50% | -0.48% | +9.01% | n/a | n/a |
| United States Revenue | 188.47M | 169.16M | 175.1M | 179.83M | 179.54M | 160.62M | 173.22M | 161.58M | 159.97M | 140.27M | 153.79M | 143.41M | 138.09M | 136.27M | 149.83M | 143.79M | 144.34M | 133.34M | 138M | 128.86M | 78.19M | 123.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +11.41% | -3.39% | -2.63% | +0.16% | +11.78% | -7.27% | +7.20% | +1.01% | +14.05% | -8.79% | +7.24% | +3.86% | +1.33% | -9.05% | +4.20% | -0.38% | +8.26% | -3.38% | +7.09% | +64.81% | -36.73% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Oct 18, 2015 | Sep 30, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 137.78M | 133.67M | 135.62M | 131.66M | 129.12M | 129.86M | 133.3M | 134.8M | 125.9M | 124.1M | 119.6M | 114.63M | 116.5M | 118.53M | 124.4M | 109.04M | 122.75M | 112.62M | 110.3M | 99.2M | 98.05M | 120.2M | 130.6M | 123.02M | 127.21M | 125.7M | 122.2M | 115.14M | 123.4M | 104.2M | 101.6M | 121.18M | 120.37M | 112.4M | 123.5M | 107.55M | 120.2M | 115.6M | 41.19M | 33.71M | 30.41M | 31.33M |
| Selling, General, and Administrative Revenue Growth | +3.08% | -1.44% | +3.01% | +1.97% | -0.57% | -2.58% | -1.11% | +7.07% | +1.45% | +3.76% | +4.34% | -1.61% | -1.71% | -4.72% | +14.08% | -11.17% | +9.00% | +2.10% | +11.19% | +1.17% | -18.43% | -7.96% | +6.17% | -3.30% | +1.20% | +2.87% | +6.14% | -6.70% | +18.43% | +2.56% | -16.16% | +0.67% | +7.09% | -8.99% | +14.83% | -10.52% | +3.98% | +180.68% | +22.19% | +10.82% | -2.92% | n/a |
| Research and Development Revenue | 47.19M | 37.88M | 43.31M | 48.8M | 44.74M | 41.86M | 46.2M | 46.5M | 51.1M | 50M | 44.9M | 35.73M | 34.2M | 40.92M | 44.1M | 42.13M | 52.56M | 44.63M | 44.5M | 47.37M | 25.15M | 35.9M | 25.9M | 45.9M | 34.54M | 43.58M | 37.6M | 42.42M | 34.2M | 31.8M | 32.5M | 31.39M | 43.01M | 29.65M | 28.4M | 32.17M | 30.2M | 31.7M | 15.25M | 10.06M | 11.37M | 10.53M |
| Research and Development Revenue Growth | +24.57% | -12.54% | -11.26% | +9.09% | +6.86% | -9.39% | -0.65% | -9.00% | +2.20% | +11.36% | +25.68% | +4.46% | -16.42% | -7.22% | +4.67% | -19.83% | +17.77% | +0.28% | -6.05% | +88.33% | -29.94% | +38.61% | -43.58% | +32.89% | -20.73% | +15.89% | -11.36% | +24.03% | +7.55% | -2.15% | +3.53% | -27.00% | +45.04% | +4.40% | -11.73% | +6.54% | -4.73% | +107.88% | +51.56% | -11.55% | +8.02% | n/a |